3 Life Sciences Services Company, Artificial Leather Maker and City Gas Distribution Company Stocks With a Strong Future Roadmap: Indegene, Mayur Uniquoters and Adani Total Gas

Pharma services, faux leather and CNG stocks give investors a way to track businesses that sit close to everyday demand in India. Indegene, Mayur Uniquoters and Adani Total Gas cover a life sciences services company, an artificial leather maker and a city gas distribution company.

This list covers three pharma services, faux leather and CNG stocks with complete current figures: Indegene, Mayur Uniquoters and Adani Total Gas. Every figure comes from the latest reported financials and the 11 November 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

What Are Pharma Services, Faux Leather and CNG Stocks?

Pharma services, faux leather and CNG stocks are listed companies that provide commercial, clinical and technology services to drug and device makers, make artificial leather for car seats, footwear and furniture, and sell CNG and piped cooking gas to vehicles, homes and factories. Their earnings depend on pharma outsourcing budgets, vehicle and footwear demand and gas volumes.

Pharma Services, Faux Leather and CNG Stocks at a Glance

On valuation, Indegene and Mayur Uniquoters trade at a P/E below the industry P/E, while Adani Total Gas trades above it, which reflects the growth the market already expects. Readers comparing pharma services, faux leather and CNG stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in pharma services, faux leather and CNG stocks can use the coming numbers to test whether growth is holding.

Why Do Pharma Services, Faux Leather and CNG Stocks Have a Strong Roadmap in India?

Pharma services, faux leather and CNG stocks have a strong roadmap in India because wider outsourcing by life sciences firms, rising vehicle output and a steady shift to cleaner gas fuels keep widening the market for these companies.

• Life sciences services. Drug makers outsource complex commercial work.
• Artificial leather. Cars and footwear use durable coated fabric.
• City gas. Households and vehicles shift to cleaner fuel.

Why Indegene Features Among These Pharma Services, Faux Leather and CNG Stocks

Among the pharma services, faux leather and CNG stocks on this list, Indegene is a Bengaluru-based healthcare technology and services company that helps biopharma and medical technology firms with commercial, medical and regulatory work using data and technology.

In the June 2026 quarter, revenue grew 39.5% year on year to Rs 1,092 crore. Revenue rose from Rs 1,690 crore in FY22 to Rs 3,582 crore in FY26, a compound annual growth rate of 20.7%.

Net profit grew from Rs 163 crore in FY22 to Rs 401 crore in FY26, which works out to a compound annual growth rate of 25.3%. The company has a return on equity of 12.8%, a debt to equity ratio of 0.05 and a market capitalisation of Rs 14,454 crore. The stock trades at a P/E of 36.0, below the industry P/E of 59.2.

Roadmap: The company is widening its digital and artificial intelligence services for life sciences clients and adding new customers across drug and device makers. Multi-year contracts with global clients support recurring revenue.

What to watch: Monitor client additions, platform adoption and growth in artificial intelligence services.

Why Mayur Uniquoters Features Among These Pharma Services, Faux Leather and CNG Stocks

Among the drug marketing support, car seat material and piped fuel shares on this list, Mayur Uniquoters is a Rajasthan-based maker of artificial leather and synthetic fabrics used in footwear, automotive upholstery, furniture and other applications.

The company has a return on equity of 16.9%, a debt to equity ratio of 0.01 and a market capitalisation of Rs 3,260 crore. The stock trades at a P/E of 15.7, below the industry P/E of 37.9.

Revenue rose from Rs 677 crore in FY22 to Rs 1,022 crore in FY26, a compound annual growth rate of 10.9%. Net profit grew from Rs 94.4 crore in FY22 to Rs 192 crore in FY26, which works out to a compound annual growth rate of 19.4%. In the June 2026 quarter, revenue grew 24.1% year on year to Rs 292 crore, while net profit rose 37.8% to Rs 56.1 crore.

Roadmap: The company supplies automotive and footwear customers in India and overseas, and demand for synthetic leather is growing as it replaces genuine leather. A debt-free balance sheet allows it to invest in new products and capacity.

What to watch: Check the volume trend in automotive and footwear customers and export sales.

Why Adani Total Gas Features Among These Pharma Services, Faux Leather and CNG Stocks

Among the three companies on this list, Adani Total Gas is a city gas distribution company that supplies piped natural gas to homes, industries and commercial users and compressed natural gas to vehicles across many cities, and it also sets up electric vehicle charging points.

Revenue rose from Rs 3,079 crore in FY22 to Rs 5,932 crore in FY26, a compound annual growth rate of 17.8%. Net profit grew from Rs 505 crore in FY22 to Rs 656 crore in FY26, which works out to a compound annual growth rate of 6.8%.

The company has a return on equity of 12.4%, a debt to equity ratio of 0.47 and a market capitalisation of Rs 58,229 crore. The stock trades at a P/E of 90.7, above the industry P/E of 13.8.

Roadmap: The company is extending its pipeline network and CNG station base into the cities it has been awarded, which widens its customer base. Rising use of cleaner fuel in households and vehicles supports volume growth.

What to watch: Track new city additions, CNG volumes and progress in electric vehicle charging.

Indegene vs Mayur Uniquoters vs Adani Total Gas on Key Financials

The table below sets the three pharma services, faux leather and CNG stocks side by side on revenue, profit and margin, using reported figures.

Mayur Uniquoters posts the highest return on equity in this group at 16.9%. Adani Total Gas has the largest FY26 revenue at Rs 5,932 crore, and Indegene shows the fastest revenue growth with a 20.7% compound annual rate. A useful habit with pharma services, faux leather and CNG stocks is to check each new quarterly result against the capacity plans the company described earlier.

Key Risks to Check Before Investing in Pharma Services, Faux Leather and CNG Stocks

Every theme carries risks that deserve a check before any decision. For these pharma services, faux leather and CNG stocks, the main points are: Long-term drug marketing support, car seat material and piped fuel shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.

• Client budgets. Spending can vary with global conditions.
• Raw material costs. Ingredient and packaging prices can move margins.
• Gas prices and rules. Gas costs and regulated tariffs can influence earnings.

Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.

Use the Univest Stock Screener to filter pharma services, faux leather and CNG stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.

Final Thoughts on Pharma Services, Faux Leather and CNG Stocks

Pharma services, faux leather and CNG stocks work best when investors track growth, valuation and return on equity side by side. Indegene, Mayur Uniquoters and Adani Total Gas each have a clear plan to grow. Based on the 11 November 2026 close, Indegene trades at Rs 616, Mayur Uniquoters at Rs 734.2 and Adani Total Gas at Rs 582.05. Valuation matters as much as growth, so compare each company's P/E with its industry P/E before adding any of these pharma services, faux leather and CNG stocks to a watchlist.

Download the Univest iOS App or Univest Android App to track pharma services, faux leather and CNG stocks, set price alerts and get research-backed stock ideas.

What are pharma services, faux leather and CNG stocks?

Ans. Pharma services, faux leather and CNG stocks are listed companies that provide commercial, clinical and technology services to drug and device makers, make artificial leather for car seats, footwear and furniture, and sell CNG and piped cooking gas to vehicles, homes and factories. Their earnings depend on pharma outsourcing budgets, vehicle and footwear demand and gas volumes. This list looks at three of them, Indegene, Mayur Uniquoters and Adani Total Gas, using reported FY22 to FY26 financials and the 11 November 2026 closing prices.

Which pharma services, faux leather and CNG stocks are covered in this list?

Ans. This list covers Indegene, Mayur Uniquoters and Adani Total Gas. Based on the 11 November 2026 close, Indegene traded at Rs 616, Mayur Uniquoters at Rs 734.2 and Adani Total Gas at Rs 582.05. Their return on equity ranges from 12.4% to 16.9%, and their revenue compound annual growth from FY22 to FY26 ranges from 10.9% to 20.7%.

Why do pharma services, faux leather and CNG stocks have a strong future roadmap in India?

Ans. Pharma services, faux leather and CNG stocks have a strong roadmap in India because wider outsourcing by life sciences firms, rising vehicle output and a steady shift to cleaner gas fuels keep widening the market for these companies. The main drivers are as follows. Life sciences services. Drug makers outsource complex commercial work. Artificial leather. Cars and footwear use durable coated fabric. City gas. Households and vehicles shift to cleaner fuel. Together these factors give the companies on this list a visible path for growth over the coming years.

How has Indegene performed financially?

Ans. Revenue rose from Rs 1,690 crore in FY22 to Rs 3,582 crore in FY26, a compound annual growth rate of 20.7%. Net profit grew from Rs 163 crore in FY22 to Rs 401 crore in FY26, which works out to a compound annual growth rate of 25.3%. In the June 2026 quarter, revenue grew 39.5% year on year to Rs 1,092 crore. The company has a return on equity of 12.8%, a debt to equity ratio of 0.05 and a market capitalisation of Rs 14,454 crore. The stock trades at a P/E of 36.0, below the industry P/E of 59.2. Looking ahead, the company is widening its digital and artificial intelligence services for life sciences clients and adding new customers across drug and device makers. Multi-year contracts with global clients support recurring revenue.

How has Mayur Uniquoters performed financially?

Ans. Revenue rose from Rs 677 crore in FY22 to Rs 1,022 crore in FY26, a compound annual growth rate of 10.9%. Net profit grew from Rs 94.4 crore in FY22 to Rs 192 crore in FY26, which works out to a compound annual growth rate of 19.4%. In the June 2026 quarter, revenue grew 24.1% year on year to Rs 292 crore, while net profit rose 37.8% to Rs 56.1 crore. The company has a return on equity of 16.9%, a debt to equity ratio of 0.01 and a market capitalisation of Rs 3,260 crore. The stock trades at a P/E of 15.7, below the industry P/E of 37.9. Looking ahead, the company supplies automotive and footwear customers in India and overseas, and demand for synthetic leather is growing as it replaces genuine leather. A debt-free balance sheet allows it to invest in new products and capacity.

How has Adani Total Gas performed financially?

Ans. Revenue rose from Rs 3,079 crore in FY22 to Rs 5,932 crore in FY26, a compound annual growth rate of 17.8%. Net profit grew from Rs 505 crore in FY22 to Rs 656 crore in FY26, which works out to a compound annual growth rate of 6.8%. The company has a return on equity of 12.4%, a debt to equity ratio of 0.47 and a market capitalisation of Rs 58,229 crore. The stock trades at a P/E of 90.7, above the industry P/E of 13.8. Looking ahead, the company is extending its pipeline network and CNG station base into the cities it has been awarded, which widens its customer base. Rising use of cleaner fuel in households and vehicles supports volume growth.

What risks should investors check before buying pharma services, faux leather and CNG stocks?

Ans. Investors should check a few risks before buying pharma services, faux leather and CNG stocks. Client budgets. Spending can vary with global conditions. Raw material costs. Ingredient and packaging prices can move margins. Gas prices and rules. Gas costs and regulated tariffs can influence earnings. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.

Is this list of pharma services, faux leather and CNG stocks investment advice?

Ans. No. This article is educational and uses publicly available data as of the 11 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.